{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:46Z","timestamp":1756902166101,"version":"3.44.0"},"reference-count":47,"publisher":"The Pediatric Pharmacy Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec id=\"st1\">\n<jats:title>OBJECTIVES<\/jats:title>\n<jats:p>This study evaluated empiric antibiotic prescribing patterns in relation to methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA) risk factors in infants with potential late-onset sepsis (LOS). Secondarily, this study evaluated rates of escalation and de-escalation from initial antibiotic choice in patients who received at least 5 days of therapy.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st2\">\n<jats:title>METHODS<\/jats:title>\n<jats:p>This was a retrospective study of infants admitted to the neonatal intensive care unit (NICU) from December 1, 2022, to May 31, 2023. Infants at least 3 days old who received antibiotics for an infectious workup were included. The prevalence of risk factors for MRSA, including low birth weight, prematurity, outborn status, length of stay, parenteral nutrition, presence of indwelling lines, and history of MRSA-positive blood culture or colonization, was compared between patients who received vancomycin empirically or an alternative agent.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st3\">\n<jats:title>RESULTS<\/jats:title>\n<jats:p>A total of 143 blood cultures were obtained from 95 patients who received antibiotics for an infectious workup during the study period. Group 1 received vancomycin and included 51 (36%) blood cultures. Group 2 received an alternative agent and included 92 (64%) blood cultures. Patients in group 1 had higher rates of every MRSA risk factor included in this study, except for patients who were outborn. Group 1 also averaged a higher total number of MRSA risk factors per patient than group 2 (4.88 vs 2.53; p &lt; 0.001).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st4\">\n<jats:title>CONCLUSION<\/jats:title>\n<jats:p>This institution uses MRSA risk factors to determine empiric antimicrobial therapy in suspected LOS. Further studies are needed to determine the relationship between the studied risk factors and incidence of MRSA infection.<\/jats:p>\n<\/jats:sec>","DOI":"10.5863\/1551-6776-30.2.198","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T14:47:41Z","timestamp":1745246861000},"page":"198-205","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective Evaluation of Empiric Vancomycin Therapy for Infectious Workups in Relation to Methicillin-Resistant Staphylococcus aureus (MRSA) Risk Factors in the Neonatal Intensive Care Unit"],"prefix":"10.5863","volume":"30","author":[{"given":"Emma","family":"Rednour","sequence":"first","affiliation":[{"name":"Pharmacy, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianna","family":"Hemmann","sequence":"additional","affiliation":[{"name":"Pharmacy, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"(4)","key":"i2331-348X-30-2-198-b01","series-title":"Pediatrics","first-page":"e1015-23","article-title":"MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis","volume":"133","author":"Zervou","year":"2014","unstructured":"Zervou FN, Zacharioudakis IM, Ziakas PD, Mylonakis E. MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics. 2014;133(4):e1015-23."},{"issue":"(2)","key":"i2331-348X-30-2-198-b02","series-title":"J Perinatol","first-page":"135","article-title":"The epidemiology of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit, 2000-2007","volume":"30","author":"Carey","year":"2010","unstructured":"Carey AJ, Duchon J, Della-Latta P, Saiman L. The epidemiology of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit, 2000-2007. J Perinatol. 2010;30(2):135\u2013139."},{"key":"i2331-348X-30-2-198-b03","series-title":"StatPearls","article-title":"Neonatal sepsis","author":"Singh","year":"2023","unstructured":"Singh M, Alsaleem M, Gray CP. Neonatal sepsis. In: StatPearls. Stat Pearls Publishing; 2023."},{"issue":"(2)","key":"i2331-348X-30-2-198-b04","series-title":"Curr Opin Pediatr","first-page":"135","article-title":"Defining neonatal sepsis","volume":"28","author":"Wynn","year":"2016","unstructured":"Wynn JL. Defining neonatal sepsis. Curr Opin Pediatr. 2016;28(2):135\u2013140."},{"issue":"(8)","key":"i2331-348X-30-2-198-b05","series-title":"Arch Dis Child","first-page":"745","article-title":"Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis","volume":"106","author":"Fleischmann","year":"2021","unstructured":"Fleischmann C, Reichert F, Cassini A, et al. Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Arch Dis Child. 2021;106(8):745\u2013752."},{"issue":"(10)","key":"i2331-348X-30-2-198-b06","series-title":"Infect Dis (Lond)","first-page":"764","article-title":"Late onset sepsis: comparison between coagulase-negative staphylococci and other bacteria in the neonatal intensive care unit","volume":"50","author":"Berlak","year":"2018","unstructured":"Berlak N, Shany E, Ben-Shimol S, et al. Late onset sepsis: comparison between coagulase-negative staphylococci and other bacteria in the neonatal intensive care unit. Infect Dis (Lond). 2018;50(10):764\u2013770."},{"issue":"(6)","key":"i2331-348X-30-2-198-b07","series-title":"Pediatrics","first-page":"1","article-title":"Late-onset sepsis among very preterm infants","volume":"150","author":"Flannery","year":"2022","unstructured":"Flannery DD, Edwards EM, Coggins SA, et al. Late-onset sepsis among very preterm infants. Pediatrics. 2022;150(6), 1\u20139."},{"issue":"(3)","key":"i2331-348X-30-2-198-b08","series-title":"Clin Infect Dis","first-page":"e18\u201355","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18\u201355."},{"issue":"(5)","key":"i2331-348X-30-2-198-b09","series-title":"J Matern Fetal Neonatal Med","first-page":"861","article-title":"Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis","volume":"35","author":"Wang","year":"2022","unstructured":"Wang J, Zhang H, Yan J, Zhang T. Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis. J Matern Fetal Neonatal Med. 2022;35(5):861\u2013870."},{"issue":"(1)","key":"i2331-348X-30-2-198-b10","series-title":"Curr Pediatr Rev","first-page":"47","article-title":"Antimicrobial stewardship in the neonatal intensive care unit: an update","volume":"15","author":"Gkentzi","year":"2019","unstructured":"Gkentzi D, Dimitriou G. Antimicrobial stewardship in the neonatal intensive care unit: an update. Curr Pediatr Rev. 2019;15(1):47\u201352."},{"issue":"(2)","key":"i2331-348X-30-2-198-b11","series-title":"J Hosp Infect","first-page":"117","article-title":"Role of antimicrobial stewardship programmes in children: a systematic review","volume":"99","author":"Araujo da Silva","year":"2018","unstructured":"Araujo da Silva AR, Albernaz de Almeida Dias DC, Marques AF, et al. Role of antimicrobial stewardship programmes in children: a systematic review. J Hosp Infect. 2018;99(2):117\u2013123."},{"issue":"(9)","key":"i2331-348X-30-2-198-b12","series-title":"J Perinatol","first-page":"1433","article-title":"Standardizing the approach to late onset sepsis in neonates through antimicrobial stewardship: a quality improvement initiative","volume":"40","author":"Lamba","year":"2020","unstructured":"Lamba V, D\u2019Souza S, Carafa C, et al. Standardizing the approach to late onset sepsis in neonates through antimicrobial stewardship: a quality improvement initiative. J Perinatol. 2020;40(9):1433\u20131440."},{"issue":"(5)","key":"i2331-348X-30-2-198-b13","series-title":"Pediatrics","first-page":"1","article-title":"Safety and efficacy of nafcillin for empiric therapy of late-onset sepsis in the NICU","volume":"149","author":"Magers","year":"2022","unstructured":"Magers J, Prusakov P, Speaks S, et al. Safety and efficacy of nafcillin for empiric therapy of late-onset sepsis in the NICU. Pediatrics. 2022;149(5), 1\u201310."},{"issue":"(5)","key":"i2331-348X-30-2-198-b14","series-title":"J Pediatr (Rio J)","first-page":"472","article-title":"Empirical antimicrobial therapy for late-onset sepsis in a neonatal unit with high prevalence of coagulase-negative Staphylococcus","volume":"92","author":"Romanelli","year":"2016","unstructured":"Romanelli RM, Anchieta LM, Bueno ESAC, et al. Empirical antimicrobial therapy for late-onset sepsis in a neonatal unit with high prevalence of coagulase-negative Staphylococcus. J Pediatr (Rio J). 2016;92(5):472\u2013478."},{"issue":"(11)","key":"i2331-348X-30-2-198-b15","series-title":"Neoreviews","first-page":"738","article-title":"Updates in late-onset sepsis: risk assessment, therapy, and outcomes","volume":"23","author":"Coggins","year":"2022","unstructured":"Coggins SA, Glaser K. Updates in late-onset sepsis: risk assessment, therapy, and outcomes. Neoreviews. 2022;23(11):738\u2013755."},{"key":"i2331-348X-30-2-198-b16","series-title":"Red Book: 2021\u20132024 Report of the Committee on Infectious Diseases","author":"Kimberlin","year":"2021","unstructured":"Committee on Infectious Diseases, Kimberlin DW, Barnett ED, et al. Red Book: 2021\u20132024 Report of the Committee on Infectious Diseases. American Academy of Pediatrics; 2021."},{"issue":"(12)","key":"i2331-348X-30-2-198-b17","series-title":"Am J Infect Control","first-page":"1388","article-title":"Risk factors for methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit: a systematic review and meta-analysis","volume":"45","author":"Washam","year":"2017","unstructured":"Washam M, Woltmann J, Haberman B, et al. Risk factors for methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit: a systematic review and meta-analysis. Am J Infect Control. 2017;45(12):1388\u20131393."},{"issue":"(7)","key":"i2331-348X-30-2-198-b18","series-title":"Am J Infect Control","first-page":"580","article-title":"An investigation of the risk factors for infection with methicillin-resistant Staphylococcus aureus among patients in a neonatal intensive care unit","volume":"37","author":"Sakaki","year":"2009","unstructured":"Sakaki H, Nishioka M, Kanda K, Takahashi Y. An investigation of the risk factors for infection with methicillin-resistant Staphylococcus aureus among patients in a neonatal intensive care unit. Am J Infect Control. 2009;37(7):580\u2013586."},{"issue":"(6)","key":"i2331-348X-30-2-198-b19","series-title":"Semin Perinatol","first-page":"424","article-title":"Methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit","volume":"36","author":"Nelson","year":"2012","unstructured":"Nelson MU, Gallagher PG. Methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit. Semin Perinatol. 2012;36(6):424\u2013430."},{"issue":"(2)","key":"i2331-348X-30-2-198-b20","series-title":"Pediatrics","first-page":"469","article-title":"Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units","volume":"118","author":"Huang","year":"2006","unstructured":"Huang YC, Chou YH, Su LH, et al. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics. 2006;118(2):469\u2013474."},{"issue":"(11)","key":"i2331-348X-30-2-198-b21","series-title":"Am J Infect Control","first-page":"1408","article-title":"Risk factors for nosocomial methicillin resistant Staphylococcus aureus (MRSA) colonization in a neonatal intensive care unit: a case-control study","volume":"49","author":"Balamohan","year":"2021","unstructured":"Balamohan A, Beachy J, Kohn N, Rubin LG. Risk factors for nosocomial methicillin resistant Staphylococcus aureus (MRSA) colonization in a neonatal intensive care unit: a case-control study. Am J Infect Control. 2021;49(11):1408\u20131413."},{"issue":"(9)","key":"i2331-348X-30-2-198-b22","series-title":"JAMA Netw Open","first-page":"e2124938","article-title":"Surveillance for colonization, transmission, and infection with methicillin-susceptible Staphylococcus aureus in a neonatal intensive care unit","volume":"4","author":"Nurjadi","year":"2021","unstructured":"Nurjadi D, Eichel VM, Tabatabai P, et al. Surveillance for colonization, transmission, and infection with methicillin-susceptible Staphylococcus aureus in a neonatal intensive care unit. JAMA Netw Open. 2021;4(9):e2124938."},{"issue":"(1)","key":"i2331-348X-30-2-198-b23","series-title":"Neonatology","first-page":"42","article-title":"Risk factors for late-onset sepsis in preterm infants: a multicenter case-control study","volume":"116","author":"El Manouni El Hassani","year":"2019","unstructured":"El Manouni El Hassani S, Berkhout DJC, Niemarkt HJ, et al. Risk factors for late-onset sepsis in preterm infants: a multicenter case-control study. Neonatology. 2019;116(1):42\u201351."},{"issue":"(5)","key":"i2331-348X-30-2-198-b24","series-title":"Pediatrics","first-page":"1","article-title":"Late-onset sepsis in very low birth weight infants","volume":"152","author":"Klinger","year":"2023","unstructured":"Klinger G, Bromiker R, Zaslavsky-Paltiel I, et al. Late-onset sepsis in very low birth weight infants. Pediatrics. 2023;152(5); 1\u201310."},{"issue":"(2 pt 1)","key":"i2331-348X-30-2-198-b25","series-title":"Pediatrics","first-page":"285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network","volume":"110","author":"Stoll","year":"2002","unstructured":"Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2 pt 1):285\u2013291."},{"issue":"(4)","key":"i2331-348X-30-2-198-b26","series-title":"J Chin Med Assoc","first-page":"507","article-title":"Risk factors and predictive markers for early and late-onset neonatal bacteremic sepsis in preterm and term infants","volume":"85","author":"Tang","year":"2022","unstructured":"Tang YH, Jeng MJ, Wang HH, et al. Risk factors and predictive markers for early and late-onset neonatal bacteremic sepsis in preterm and term infants. J Chin Med Assoc. 2022;85(4):507\u2013513."},{"issue":"(12)","key":"i2331-348X-30-2-198-b27","series-title":"Pediatr Infect Dis J","first-page":"1236","article-title":"Early-onset sepsis among preterm neonates in China, 2015 to 2018","volume":"38","author":"Jiang","year":"2019","unstructured":"Jiang S, Hong L, Gai J, et al. Early-onset sepsis among preterm neonates in China, 2015 to 2018. Pediatr Infect Dis J. 2019;38(12):1236\u20131241."},{"issue":"(4)","key":"i2331-348X-30-2-198-b28","series-title":"JAMA Pediatr","first-page":"361","article-title":"Cognitive outcomes of children born extremely or very preterm since the 1990s and associated risk factors: a meta-analysis and meta-regression","volume":"172","author":"Twilhaar","year":"2018","unstructured":"Twilhaar ES, Wade RM, de Kieviet JF, et al. Cognitive outcomes of children born extremely or very preterm since the 1990s and associated risk factors: a meta-analysis and meta-regression. JAMA Pediatr. 2018;172(4):361\u2013367."},{"issue":"(5)","key":"i2331-348X-30-2-198-b29","series-title":"Public Health","first-page":"399","article-title":"Outcomes in preterm infants","volume":"128","author":"Platt","year":"2014","unstructured":"Platt MJ. Outcomes in preterm infants. Public Health. 2014;128(5):399\u2013403."},{"issue":"(1)","key":"i2331-348X-30-2-198-b30","series-title":"Antimicrob Steward Healthc Epidemiol","first-page":"e167","article-title":"Use of nares swab to de-escalate vancomycin for patients with suspected methicillin-resistant Staphylococcus aureus","volume":"3","author":"Gentges","year":"2023","unstructured":"Gentges J, El-Kouri N, Rahman T, et al. Use of nares swab to de-escalate vancomycin for patients with suspected methicillin-resistant Staphylococcus aureus. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e167."},{"issue":"(24)","key":"i2331-348X-30-2-198-b31","series-title":"Am J Health Syst Pharm","first-page":"2236","article-title":"Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit","volume":"78","author":"Diep","year":"2021","unstructured":"Diep C, Meng L, Pourali S, et al. Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit. Am J Health Syst Pharm. 2021;78(24):2236\u20132244."},{"issue":"(2)","key":"i2331-348X-30-2-198-b32","series-title":"Hosp Pediatr","first-page":"e113","article-title":"Methicillin-resistant Staphylococcus aureus surveillance testing: more than meets the nare","volume":"14","author":"Symons","year":"2024","unstructured":"Symons E, VanWanzeele D, McCulloh R. Methicillin-resistant Staphylococcus aureus surveillance testing: more than meets the nare. Hosp Pediatr. 14 (2):e113\u2013e115.2024."},{"issue":"(4)","key":"i2331-348X-30-2-198-b33","series-title":"Open Forum Infect Dis","first-page":"ofz062","article-title":"The association between the developing nasal microbiota of hospitalized neonates and Staphylococcus aureus colonization","volume":"6","author":"Khamash","year":"2019","unstructured":"Khamash DF, Mongodin EF, White JR, et al. The association between the developing nasal microbiota of hospitalized neonates and Staphylococcus aureus colonization. Open Forum Infect Dis. 2019;6(4):ofz062."},{"issue":"(1)","key":"i2331-348X-30-2-198-b34","series-title":"Pediatrics","first-page":"1","article-title":"Mupirocin for Staphylococcus aureus decolonization of infants in neonatal intensive care units","volume":"143","author":"Kotloff","year":"2019","unstructured":"Kotloff KL, Shirley DT, Creech CB, et al. Mupirocin for Staphylococcus aureus decolonization of infants in neonatal intensive care units. Pediatrics. 2019;143(1); 1\u201311."},{"issue":"(8)","key":"i2331-348X-30-2-198-b35","series-title":"Infect Control Hosp Epidemiol","first-page":"930","article-title":"Bacterial infections in neonates following mupirocin-based MRSA decolonization: a multicenter cohort study","volume":"38","author":"Pierce","year":"2017","unstructured":"Pierce R, Bryant K, Elward A, et al. Bacterial infections in neonates following mupirocin-based MRSA decolonization: a multicenter cohort study. Infect Control Hosp Epidemiol. 2017;38(8):930\u2013936."},{"issue":"(3)","key":"i2331-348X-30-2-198-b36","series-title":"Lancet Child Adolesc Health","first-page":"184","article-title":"Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study","volume":"1","author":"Jetton","year":"2017","unstructured":"Jetton JG, Boohaker LJ, Sethi SK, et al. Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc Health. 2017;1(3):184\u2013194."},{"issue":"(5)","key":"i2331-348X-30-2-198-b37","series-title":"Pediatrics","first-page":"1","article-title":"Advances in neonatal acute kidney injury","volume":"148","author":"Starr","year":"2021","unstructured":"Starr MC, Charlton JR, Guillet R, et al. Advances in neonatal acute kidney injury. Pediatrics. 2021;148(5), 1\u201314."},{"issue":"(2)","key":"i2331-348X-30-2-198-b38","series-title":"Curr Opin Pediatr","first-page":"180","article-title":"Drug-induced acute kidney injury in neonates","volume":"28","author":"Hanna","year":"2016","unstructured":"Hanna MH, Askenazi DJ, Selewski DT. Drug-induced acute kidney injury in neonates. Curr Opin Pediatr. 2016;28(2):180\u2013187."},{"key":"i2331-348X-30-2-198-b39","series-title":"J Pediatr","first-page":"223","article-title":"Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action): reduction of nephrotoxic medication-associated acute kidney injury in the neonatal intensive care unit","volume":"215","author":"Stoops","year":"2019","unstructured":"Stoops C, Stone S, Evans E, et al. Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action): reduction of nephrotoxic medication-associated acute kidney injury in the neonatal intensive care unit. J Pediatr. 2019;215:223\u2013228 e6."},{"issue":"(4)","key":"i2331-348X-30-2-198-b40","series-title":"J Pediatr Pharmacol Ther","first-page":"287","article-title":"Implementation strategies for Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) to prevent neonatal medication-induced kidney injury","volume":"28","author":"Stone","year":"2023","unstructured":"Stone SB, Bisaccia E, Zakhary MS, et al. Implementation strategies for Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) to prevent neonatal medication-induced kidney injury. J Pediatr Pharmacol Ther. 2023;28(4):287\u2013296."},{"issue":"(4)","key":"i2331-348X-30-2-198-b41","series-title":"Pediatr Infect Dis J","first-page":"273","article-title":"Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit","volume":"30","author":"Chiu","year":"2011","unstructured":"Chiu CH, Michelow IC, Cronin J, et al. Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit. Pediatr Infect Dis J. 2011;30(4):273\u2013278."},{"issue":"(2)","key":"i2331-348X-30-2-198-b42","series-title":"Infect Dis Clin North Am","first-page":"247","article-title":"Antimicrobial stewardship in the NICU","volume":"28","author":"Cantey","year":"2014","unstructured":"Cantey JB, Patel SJ. Antimicrobial stewardship in the NICU. Infect Dis Clin North Am. 2014;28(2):247\u2013261."},{"issue":"(3)","key":"i2331-348X-30-2-198-b43","series-title":"Pediatr Qual Saf","first-page":"e659","article-title":"New strategies to reduce unnecessary antibiotic use in the NICU: a quality improvement initiative","volume":"8","author":"Pantoja","year":"2023","unstructured":"Pantoja A, Sveum S, Frost S, et al. New strategies to reduce unnecessary antibiotic use in the NICU: a quality improvement initiative. Pediatr Qual Saf. 2023;8(3):e659."},{"issue":"(9)","key":"i2331-348X-30-2-198-b44","series-title":"Hosp Pediatr","first-page":"936","article-title":"Using electronic health record tools to decrease antibiotic exposure in infant sepsis evaluation","volume":"11","author":"Bauer","year":"2021","unstructured":"Bauer SC, Kaeppler C, Soung P, et al. Using electronic health record tools to decrease antibiotic exposure in infant sepsis evaluation. Hosp Pediatr. 2021;11(9):936\u2013943."},{"issue":"(10)","key":"i2331-348X-30-2-198-b45","series-title":"Lancet Infect Dis","first-page":"1178","article-title":"Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study","volume":"16","author":"Cantey","year":"2016","unstructured":"Cantey JB, Wozniak PS, Pruszynski JE, Sanchez PJ. Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study. Lancet Infect Dis. 2016;16(10):1178\u20131184."},{"issue":"(5)","key":"i2331-348X-30-2-198-b46","series-title":"Pediatr Infect Dis J","first-page":"528","article-title":"Minimum duration of antibiotic treatment based on blood culture in rule out neonatal sepsis","volume":"38","author":"Ur Rehman Durrani","year":"2019","unstructured":"Ur Rehman Durrani N, Rochow N, Alghamdi J, et al. Minimum duration of antibiotic treatment based on blood culture in rule out neonatal sepsis. Pediatr Infect Dis J. 2019;38(5):528\u2013532."},{"issue":"(1)","key":"i2331-348X-30-2-198-b47","series-title":"Crit Care","first-page":"12","article-title":"Association of inflammatory biomarkers with subsequent clinical course in suspected late onset sepsis in preterm neonates","volume":"25","author":"Kurul","year":"2021","unstructured":"Kurul S, Simons SHP, Ramakers CRB, et al. Association of inflammatory biomarkers with subsequent clinical course in suspected late onset sepsis in preterm neonates. Crit Care. 2021;25(1):12."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/30\/2\/article-p198.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/30\/2\/article-p198.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/30\/2\/article-p198.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T14:47:41Z","timestamp":1745246861000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/30\/2\/article-p198.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":47,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-30.2.198","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"type":"electronic","value":"2331-348X"},{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}